919354-52-2 Usage
Uses
Used in Pharmaceutical Industry:
3-Pyridinecarboxylic acid, 2,6-dichloro-5-cyano-, ethyl ester is used as a building block for the synthesis of various pharmaceuticals, due to its versatile intermediate properties and its role in the production of antiviral and antineoplastic agents.
Used in Medicinal Chemistry Research:
3-Pyridinecarboxylic acid, 2,6-dichloro-5-cyano-, ethyl ester is used as a valuable tool for researchers and scientists in the pharmaceutical field, enabling the exploration of its unique structure and reactivity for the development of new drugs.
Used in Agrochemicals Industry:
3-Pyridinecarboxylic acid, 2,6-dichloro-5-cyano-, ethyl ester has potential applications in the agrochemicals industry, where its chemical properties can be utilized for the development of new agrochemical products.
Used in Materials Science:
3-Pyridinecarboxylic acid, 2,6-dichloro-5-cyano-, ethyl ester also has potential applications in materials science, where its unique structure and reactivity can contribute to the advancement of new materials and technologies.
Check Digit Verification of cas no
The CAS Registry Mumber 919354-52-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,9,3,5 and 4 respectively; the second part has 2 digits, 5 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 919354-52:
(8*9)+(7*1)+(6*9)+(5*3)+(4*5)+(3*4)+(2*5)+(1*2)=192
192 % 10 = 2
So 919354-52-2 is a valid CAS Registry Number.
919354-52-2Relevant academic research and scientific papers
BENZAMIDES AND NICOTINAMIDES AS SYK MODULATORS
-
Page/Page column 146, (2012/05/20)
The present invention is directed to compounds of formula I and pharmaceutically acceptable salts, esters, and prodrugs thereof which are inhibitors of Syk kinase. The present invention is also directed to intermediates used in making such compounds, the preparation of such a compound, pharmaceutical compositions containing such a compound, methods of inhibition Syk kinase activity, methods of inhibition the platelet aggregation, and methods to prevent or treat a number of conditions mediated at least in part by Syk kinase activity, such as Non Hodgkin's Lymphoma.
NEW PYRIDINE ANALOGUES
-
Page/Page column 185, (2008/06/13)
The present invention relates to certain new pyridin analogues of Formula (I) Chemical formula should be inserted here. Please see paper copy Formula (I) to processes for preparing such compounds, to their utility as P2Y12 inhibitors and as anti-trombotic agents etc, their use as medicaments in cardiovascular diseases as well as pharmaceutical compositions containing them.
